01. Doctor Overview

Doctor Overview

Dr. Alice Boylan currently serves as chief of Acute, Critical and Trauma at the Integrated Center of Clinical Excellence at the Medical University of South Carolina (MUSC) located in Charleston. Prior to assuming her post at MUSC in 1995, Dr. Boylan served on the faculty at the University of California San Francisco (UCSF).

Board-certified in internal medicine, pulmonary disease and critical care medicine, Dr. Boylan’s clinical expertise and research interests focus on the diagnosis and treatment of critically ill patients, including those with mesothelioma.

Dr. Boylan is a noted lecturer both nationally and internationally. She has been the recipient of numerous research grants over the past 20 years serving as lead investigator of these scientific and clinical endeavors.

02. Fast Facts

Doctor Fast Facts

Main Specialty: Pulmonology

Other Interests & Specialties: Pulmonary medicine, acute renal failure, benign prostatic hypertrophy, chronic renal disease, cirrhosis, cystic fibrosis, dehydration, emphysema, heart failure, obstructive sleep apnea, overweight and obesity, pneumonia, pulmonary embolism, sarcoidosis and the treatment of critically ill patients.

Certifications, Awards & Accolades: American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Certification in Critical Care Medicine, American Board of Internal Medicine Certification in Pulmonary Disease, MUSC Outstanding Clinician Award, member of the American Thoracic Society, member of the Society of Critical Care Medicine, member of the International Mesothelioma Interest Group (iMig)

Education & Experience:

• Medical Degree from Lewis Katz School of Medicine at Temple University
• Internship in Internal Medicine at Dartmouth-Hitchcock Medical Center
• Residency in Internal Medicine at Dartmouth-Hitchcock Medical Center
• Fellowship in Pulmonary Disease and Critical Care at University of California at San Francisco

03. Publications

Publications

Mesothelioma: New Concepts in Diagnosis and Management. Current Opinion in Pulmonary Medicine. March 2000; 6(2):157-163.

Co-ordinated over-expression of the MRP and gamma-glutamylcysteine synthetase genes, but not MDR1, correlates with doxorubicin resistance in human malignant mesothelioma cell lines. International Journal of Medicine. March 1998;75(5):757-61.

CaSm (LSm-1) overexpression in lung cancer and mesothelioma is required for transformed phenotypes. American Journal of Respiratory Cell and Molecular Biology. June 2008;38(6):671-8. doi: 10.1165/rcmb.2007-0205OC